Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Telotristat

Generic Name: Telotristat

Brand Names: Xermelo

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₂₂ClF_₃N_₆O_₃

CAS Number: 1033805-28-5

Unique Ingredient Identifier: 381V4FCV2Z

Overview

A tryptophan hydroxylase inhibitor. Telotristat ethyl (brand name Xermelo) is a prodrug of telotristat.

Background

A tryptophan hydroxylase inhibitor. Telotristat ethyl (brand name Xermelo) is a prodrug of telotristat.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors

Phase 2

Withdrawn

Posted: 2020/12/17

Sponsor:University of Chicag...

ID:NCT04672876

Telotristat With Lutathera in Neuroendocrine Tumors

Phase 2

Terminated

Posted: 2020/09/10

Sponsor:

Lowell Anthony, MD

ID:NCT04543955

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Phase 2

Completed

Posted: 2018/03/05

Sponsor:Barbara Ann Karmanos...

ID:NCT03453489

Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function

Phase 1

Completed

Posted: 2018/02/22

Sponsor:Ipsen

ID:NCT03442725

A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects

Phase 1

Completed

Posted: 2017/10/05

Sponsor:Lexicon Pharmaceutic...

ID:NCT03302845

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy